Phase II Evaluation of EMD121974 (NSC 707544, Cilengitide) in Patients With Non-Metastatic Androgen-Independent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 02 May 2016
At a glance
- Drugs Cilengitide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.
- 23 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.